Q2 EPS Forecast for Atea Pharmaceuticals Reduced by Analyst
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) – William Blair cut their Q2 2025 earnings per share estimates for shares of Atea Pharmaceuticals in a report issued on Tuesday, May 13th. William Blair analyst A. Hsieh now anticipates that the company will earn ($0.45) per share for the quarter, down from their prior forecast of […]
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) – William Blair cut their Q2 2025 earnings per share estimates for shares of Atea Pharmaceuticals in a report issued on Tuesday, May 13th. William Blair analyst A. Hsieh now anticipates that the company will earn ($0.45) per share for the quarter, down from their prior forecast of […]
